ArticleDiabetes, obesity & metabolism2026

Enavogliflozin Improves Non-invasive Hepatic Steatosis Indices in Patients With Type 2 Diabetes: A Pooled Analysis of Three Randomised Trials.

Min Kyoung Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.